Melatonin and genital endometriosis - new possibilities of therapy

M.I. Yarmolinskaya Yarmolinskaya, Daniil Vladislavovich Zaytsev, Saimat Shaualovna Tkhazaplizheva
In: Journal of obstetrics and women's diseases · 2015 · vol. 64(1) , pp. 67–75 · doi:10.17816/jowd64167-75 · W2476029147
article OA: hybrid CC0 ⤵ 5 in-corpus citations
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Melatonin's anti-estrogenic, anti-inflammatory, antioxidant, antiangiogenic, proapoptotic, antiproliferative, and analgesic properties suggest its potential as a pathogenetically justified treatment for genital endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Presented literature review describes anti-estrogenic, anti-inflammatory, antioxidant, antiangiogenic, proapoptotic, antiproliferative and analgesic effects of melatonin, that allow to consider it as pathogenetically proved medication for treatment of genital endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (37)

Cited by (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK